Literature DB >> 25400473

Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection.

Ioana Grigorescu1, Dan Lucian Dumitrascu1.   

Abstract

AIM: To describe spontaneous, or interferon (IFN)- or immunization-induced skin lesions in hepatitis B virus (HBV) infection.
METHODS: A comprehensive literature search of all the papers presenting case reports of dermatological lesions in patients with chronic HBV infection was carried out. We included only patients with histologically proven skin lesions that appeared in the normal course of hepatitis B infection, or after immunization for hepatitis B or antiviral treatment.
RESULTS: We found 44 papers on this topic, reporting 151 cases. About 2% of patients with hepatitis B infection, mainly men, presented with skin lesions. Among patients with chronic hepatitis B, vasculitis and essential mixed cryoglobulinemia seemed to be the most frequent skin lesion (53.3%), followed by papular changes, rashes and Gianotti-Crosti syndrome, skin carcinoma and Henoch-Schönlein purpura were rare. IFN treatment seemed to be effective against HBV-associated and immunoglobulin-complex-mediated disease (vasculitis). Two cutaneous lesions (lichen planus and granuloma annulare) were described after hepatitis B vaccination. Systemic lupus and lupus-like lesions were the most frequently encountered lesions after antiviral treatment. Immunosuppressive and steroid therapy ameliorates lichen planus lesions in 50% of cases.
CONCLUSION: Vasculitis was the most frequent spontaneous skin lesion found in chronic hepatitis B. Lichen planus was most frequent after immunization and lupus/lupus-like lesions after IFN.

Entities:  

Keywords:  Adverse effects; Hepatitis B; Immunization; Skin diseases

Mesh:

Substances:

Year:  2014        PMID: 25400473      PMCID: PMC4229554          DOI: 10.3748/wjg.v20.i42.15860

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Lichenoid eruption following hepatitis B vaccination: first North American case report.

Authors:  A Usman; A Kimyai-Asadi; M J Stiller; M Alam
Journal:  Pediatr Dermatol       Date:  2001 Mar-Apr       Impact factor: 1.588

2.  Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment.

Authors:  C García-Porrúa; M A González-Gay; F Fernández-Lamelo; J M Paz-Carreira; E Lavilla; M A González-López
Journal:  Clin Exp Rheumatol       Date:  1998 Jan-Feb       Impact factor: 4.473

3.  Association between hepatitis B virus and essential mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; D Zucker-Franklin; E C Franklin
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

4.  Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.

Authors:  L La Civita; A L Zignego; F Lombardini; M Monti; G Longombardo; G Pasero; C Ferri
Journal:  J Rheumatol       Date:  1996-09       Impact factor: 4.666

5.  Acute onset distal symmetrical vasculitic polyneuropathy associated with acute hepatitis B.

Authors:  Manmohan Mehndiratta; Sanjay Pandey; Rajeev Nayak; Ravindra K Saran
Journal:  J Clin Neurosci       Date:  2012-11-17       Impact factor: 1.961

6.  Cutaneous polyarteritis nodosa in children.

Authors:  Basil M Fathalla; Laurie Miller; Stephen Brady; Jane G Schaller
Journal:  J Am Acad Dermatol       Date:  2005-10       Impact factor: 11.527

7.  Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier.

Authors:  Tomoyuki Yamazaki; Tetsu Akimoto; Kousuke Okuda; Taro Sugase; Eri Takeshima; Akihiko Numata; Yoshiyuki Morishita; Yoshitaka Iwazu; Hiromichi Yoshizawa; Takanori Komada; Kana Iwazu; Osamu Saito; Fumi Takemoto; Shigeaki Muto; Eiji Kusano
Journal:  Intern Med       Date:  2012-03-01       Impact factor: 1.271

8.  Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B.

Authors:  Elif Doyuk Kartal; Saygin Nayman Alpat; Ilhan Ozgunes; Gaye Usluer
Journal:  Adv Ther       Date:  2007 Sep-Oct       Impact factor: 3.845

9.  [Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy].

Authors:  T Glück; P Weber; K H Wiedmann
Journal:  Dtsch Med Wochenschr       Date:  1994-10-14       Impact factor: 0.628

10.  Lichen planus secondary to hepatitis B vaccination.

Authors:  Akhilesh Agrawal; Shrutakirti D Shenoi
Journal:  Indian J Dermatol Venereol Leprol       Date:  2004 Jul-Aug       Impact factor: 2.545

View more
  5 in total

1.  Digital ischemic necrosis with cryoglobulinemia associated with hepatitis B infection.

Authors:  Ferhat Arslan; Ergenekon Karagöz; Ali Mert
Journal:  J Orthop       Date:  2015-10-20

2.  Hepatitis B, interferon, and acne fulminans in a young girl.

Authors:  Sandeep Arora; Ajay Malik; Dharmendra Kumar; Neha Sodhi
Journal:  Indian Dermatol Online J       Date:  2016 Mar-Apr

3.  Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B.

Authors:  Ellie Choi; Pang Yin Huei; Sam Yang
Journal:  JAAD Case Rep       Date:  2018-03-06

Review 4.  Human hepatitis viruses-associated cutaneous and systemic vasculitis.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

5.  Skin manifestations associated with systemic diseases - Part II.

Authors:  Juliana Martins Leal; Gabriela Higino de Souza; Paula Figueiredo de Marsillac; Alexandre Carlos Gripp
Journal:  An Bras Dermatol       Date:  2021-09-17       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.